病理におけるAI市場、シェア、規模、動向、産業分析レポート：コンポーネント別、ニューラルネットワーク別、用途別、エンドユーザー別、地域別、セグメント別予測、2023年～2032年

Polaris Market Research社の最新調査によると、病理におけるAIの世界市場規模は2032年までに8,971万米ドルに達する見込みです。このレポートは現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

当初、病理医は顕微鏡を使って病理スライドを検査していました。目視観察と主観的な解釈は、観察者内および観察者間の不一致を防ぐのに効果がなくなってきました。自動化されたアプローチは、主にデジタル画像を通して、結果の速度と精度を向上させるためです。2022年にPubMed Centralで発表された最近の研究では、病理におけるAIの応用が動向や課題とともに評価されました。

コンピュータ用途におけるAIの利用が高まり、病理医の間で支持を集めています。人工知能の進化は、ディープラーニングとともに、デジタル病理学を背景とした画像ベースの診断を可能にしています。さらに、病理医による人工知能の使用は、時間の節約とエラーの減少につながり、今後数年間は主に症例数の多い検査室での使用を促進します。

世界レベルでデジタル病理検査室の導入が進んでいることが、病理学の様々な作業における人工知能の使用を促進しています。2023年に発表された研究では、病理検査室のデジタル化の見直しに焦点が当てられています。そこでは、症例の読影時間の短縮やセカンドオピニオンの必要性など、デジタル化の利点が明らかにされています。デジタル病理学は、病気や症状、疾患の特定に機械学習と人工知能を使用するため、診断プロセスをより迅速かつ効率的にします。これにより、科学者や医師は最善の治療法を選択できるようになり、結果として患者の転帰が改善されます。

研究者が病理学における人工知能の信頼性を確認するために名乗りを上げるにつれて、医師の間でも人工知能に対する認識が高まり、今後数年間で採用率が高まる可能性があります。

病理におけるAI市場レポートハイライト

ソフトウェアセグメントは、高度なアルゴリズムと診断の改善により、今後数年間で最も高い成長が見込まれます。

画像解析におけるAIの応用により、従来のニューラルネットワークセグメントが最大の市場シェアを占めています。

創薬セグメントは、個別化された薬物療法を提供する能力により、収益シェアが大きくなると予測されています。

病院と標準検査室セグメントは、病理学に関連する症例数が多いことから、大きな成長が見込まれています。

アジア太平洋は、ヘルスケアAI市場の成長により、調査期間中に最大の成長率を記録すると予測されています。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界の病理におけるAI市場洞察

• 病理におけるAI-業界スナップショット
• 病理市場力学におけるAI
  • 促進要因と機会
    • 病気の世界の蔓延により、人工知能の活用が促進されている
    • AIの統合による精密医療の進歩
  • 抑制要因と課題
    • 統合の課題とワークフローの中断
• PESTLE分析
• 病理業界におけるAIの動向
• バリューチェーン分析
• COVID-19感染症の影響分析

第5章 世界の病理におけるAI市場、ニューラルネットワーク別

• 主な調査結果
• イントロダクション
• 敵対的生成ネットワーク（GANS）
• 畳み込みニューラルネットワーク（CNN）
• リカレントニューラルネットワーク（RNN）
• その他

第6章 世界の病理におけるAI市場、コンポーネント別

• 主な調査結果
• イントロダクション
• ソフトウェア
• スキャナー

第7章 世界の病理におけるAI市場、用途別

• 主な調査結果
• イントロダクション
• 創薬
• 病気の診断と予後
• 臨床ワークフロー
• トレーニングと教育

第8章 世界の病理におけるAI市場、最終用途別

• 主な調査結果
• イントロダクション
• 製薬およびバイオテクノロジー企業
• 病院および参考検査機関
• 学術調査機関

第9章 世界の病理におけるAI市場、地域別

• 主な調査結果
• イントロダクション
  • 病理におけるAI市場評価、地域別、2019-2032年
• 病理におけるAI市場-北米
  • 北米：病理におけるAI市場、ニューラルネットワーク別、2019～2032年
  • 北米：病理におけるAI市場、最終用途別、2019～2032年
  • 北米：病理におけるAI市場、コンポーネント別、2019～2032年
  • 北米：病理におけるAI市場、用途別、2019-2032年
  • 病理におけるAI市場-米国
  • 病理におけるAI市場-カナダ
• 病理におけるAI市場-欧州
  • 欧州：病理におけるAI市場、ニューラルネットワーク別、2019～2032年
  • 欧州：病理におけるAI市場、最終用途別、2019～2032年
  • 欧州：病理におけるAI市場、コンポーネント別、2019～2032年
  • 欧州：病理におけるAI市場、用途別、2019～2032年
  • 病理におけるAI市場-英国
  • 病理におけるAI市場-フランス
  • 病理におけるAI市場-ドイツ
  • 病理におけるAI市場-イタリア
  • 病理におけるAI市場-スペイン
  • 病理におけるAI市場-オランダ
  • 病理におけるAI市場-ロシア
• 病理におけるAI市場-アジア太平洋
  • アジア太平洋：病理におけるAI市場、ニューラルネットワーク別、2019～2032年
  • アジア太平洋：病理におけるAI市場、エンドユース別、2019～2032年
  • アジア太平洋：病理におけるAI市場、コンポーネント別、2019～2032年
  • アジア太平洋：病理におけるAI市場、用途別、2019～2032年
  • 病理におけるAI市場-中国
  • 病理におけるAI市場-インド
  • 病理におけるAI市場-日本
  • 病理におけるAI市場-マレーシア
  • 病理におけるAI市場-インドネシア
  • 病理におけるAI市場-韓国
• 病理におけるAI市場-中東およびアフリカ
  • 中東およびアフリカ：病理におけるAI市場、ニューラルネットワーク別、2019～2032年
  • 中東およびアフリカ：病理におけるAI市場、最終用途別、2019～2032年
  • 中東およびアフリカ：病理におけるAI市場、コンポーネント別、2019～2032年
  • 中東およびアフリカ：病理におけるAI市場、用途別、2019～2032年
  • 病理におけるAI市場-サウジアラビア
  • 病理におけるAI市場-南アフリカ
  • 病理におけるAI市場-イスラエル
  • 病理におけるAI市場-アラブ首長国連邦
• 病理におけるAI市場-ラテンアメリカ
  • ラテンアメリカ：病理におけるAI市場、ニューラルネットワーク別、2019～2032年
  • ラテンアメリカ：病理におけるAI市場、最終用途別、2019～2032年
  • ラテンアメリカ：病理におけるAI市場、コンポーネント別、2019-2032年
  • ラテンアメリカ：病理におけるAI市場、用途別、2019-2032年
  • 病理におけるAI市場-メキシコ
  • 病理におけるAI市場-ブラジル
  • 病理におけるAI市場-アルゼンチン

第10章 競合情勢

• 拡張と買収の分析
  • 拡大
  • 買収
• 提携/協業/合意/公開

第11章 企業プロファイル

• 4D Path
• Aiforia Technologies
• Aiosyn
• Akoya Biosciences
• deepPath
• Deep Bio
• DoMore Diagnostics AS
• F. Hoffmann-La Roche
• Hologic
• Ibex Medical Analytics
• Indica Labs
• Konfoong Biotech International
• Koninklijke Philips N.V.
• Lumea
• Mindpeak

List of Tables

• Table 1 Global AI in Pathology Market, by Neural Network, by Region, 2019-2032 (USD Million)
• Table 2 Global AI in Pathology Market, by Component, by Region, 2019-2032 (USD Million)
• Table 3 Global AI in Pathology Market, by Application, by Region, 2019-2032 (USD Million)
• Table 4 Global AI in Pathology Market, by End Use, by Region, 2019-2032 (USD Million)
• Table 5 AI in Pathology Market Assessment, By Geography, 2019-2032 (USD Million)
• Table 6 North America: AI in Pathology Market, by Neural Network, 2019-2032 (USD Million)
• Table 7 North America: AI in Pathology Market, by Component, 2019-2032 (USD Million)
• Table 8 North America: AI in Pathology Market, by Application, 2019-2032 (USD Million)
• Table 9 North America: AI in Pathology Market, by End Use, 2019-2032 (USD Million)
• Table 10 U.S.: AI in Pathology Market, by Neural Network, 2019-2032 (USD Million)
• Table 11 U.S.: AI in Pathology Market, by Component, 2019-2032 (USD Million)
• Table 12 U.S.: AI in Pathology Market, by Application, 2019-2032 (USD Million)
• Table 13 U.S.: AI in Pathology Market, by End Use, 2019-2032 (USD Million)
• Table 14 Canada: AI in Pathology Market, by Neural Network, 2019-2032 (USD Million)
• Table 15 Canada: AI in Pathology Market, by Component, 2019-2032 (USD Million)
• Table 16 Canada: AI in Pathology Market, by Application, 2019-2032 (USD Million)
• Table 17 Canada: AI in Pathology Market, by End Use, 2019-2032 (USD Million)
• Table 18 Europe: AI in Pathology Market, by Neural Network, 2019-2032 (USD Million)
• Table 19 Europe: AI in Pathology Market, by Component, 2019-2032 (USD Million)
• Table 20 Europe: AI in Pathology Market, by Application, 2019-2032 (USD Million)
• Table 21 Europe: AI in Pathology Market, by End Use, 2019-2032 (USD Million)
• Table 22 Germany: AI in Pathology Market, by Neural Network, 2019-2032 (USD Million)
• Table 23 Germany: AI in Pathology Market, by Component, 2019-2032 (USD Million)
• Table 24 Germany: AI in Pathology Market, by Application, 2019-2032 (USD Million)
• Table 25 Germany: AI in Pathology Market, by End Use, 2019-2032 (USD Million)
• Table 26 France: AI in Pathology Market, by Neural Network, 2019-2032 (USD Million)
• Table 27 France: AI in Pathology Market, by Component, 2019-2032 (USD Million)
• Table 28 France: AI in Pathology Market, by Application, 2019-2032 (USD Million)
• Table 29 France: AI in Pathology Market, by End Use, 2019-2032 (USD Million)
• Table 30 UK: AI in Pathology Market, by Neural Network, 2019-2032 (USD Million)
• Table 31 UK: AI in Pathology Market, by Component, 2019-2032 (USD Million)
• Table 32 UK: AI in Pathology Market, by Application, 2019-2032 (USD Million)
• Table 33 UK: AI in Pathology Market, by End Use, 2019-2032 (USD Million)
• Table 34 Italy: AI in Pathology Market, by Neural Network, 2019-2032 (USD Million)
• Table 35 Italy: AI in Pathology Market, by Component, 2019-2032 (USD Million)
• Table 36 Italy: AI in Pathology Market, by Application, 2019-2032 (USD Million)
• Table 37 Italy: AI in Pathology Market, by End Use, 2019-2032 (USD Million)
• Table 38 Netherlands: AI in Pathology Market, by Neural Network, 2019-2032 (USD Million)
• Table 39 Netherlands: AI in Pathology Market, by Component, 2019-2032 (USD Million)
• Table 40 Netherlands: AI in Pathology Market, by Application, 2019-2032 (USD Million)
• Table 41 Netherlands: AI in Pathology Market, by End Use, 2019-2032 (USD Million)
• Table 42 Spain: AI in Pathology Market, by Neural Network, 2019-2032 (USD Million)
• Table 43 Spain: AI in Pathology Market, by Component, 2019-2032 (USD Million)
• Table 44 Spain: AI in Pathology Market, by Application, 2019-2032 (USD Million)
• Table 45 Spain: AI in Pathology Market, by End Use, 2019-2032 (USD Million)
• Table 46 Russia: AI in Pathology Market, by Neural Network, 2019-2032 (USD Million)
• Table 47 Russia: AI in Pathology Market, by Component, 2019-2032 (USD Million)
• Table 48 Russia: AI in Pathology Market, by Application, 2019-2032 (USD Million)
• Table 49 Russia: AI in Pathology Market, by End Use, 2019-2032 (USD Million)
• Table 50 Asia Pacific: AI in Pathology Market, by Neural Network, 2019-2032 (USD Million)
• Table 51 Asia Pacific: AI in Pathology Market, by Component, 2019-2032 (USD Million)
• Table 52 Asia Pacific: AI in Pathology Market, by Application, 2019-2032 (USD Million)
• Table 53 Asia Pacific: AI in Pathology Market, by End Use, 2019-2032 (USD Million)
• Table 54 China: AI in Pathology Market, by Neural Network, 2019-2032 (USD Million)
• Table 55 China: AI in Pathology Market, by Component, 2019-2032 (USD Million)
• Table 56 China: AI in Pathology Market, by Application, 2019-2032 (USD Million)
• Table 57 China: AI in Pathology Market, by End Use, 2019-2032 (USD Million)
• Table 58 Japan: AI in Pathology Market, by Neural Network, 2019-2032 (USD Million)
• Table 59 Japan: AI in Pathology Market, by Component, 2019-2032 (USD Million)
• Table 60 Japan: AI in Pathology Market, by Application, 2019-2032 (USD Million)
• Table 61 Japan: AI in Pathology Market, by End Use, 2019-2032 (USD Million)
• Table 62 India: AI in Pathology Market, by Neural Network, 2019-2032 (USD Million)
• Table 63 India: AI in Pathology Market, by Component, 2019-2032 (USD Million)
• Table 64 India: AI in Pathology Market, by Application, 2019-2032 (USD Million)
• Table 65 India: AI in Pathology Market, by End Use, 2019-2032 (USD Million)
• Table 66 Indonesia: AI in Pathology Market, by Neural Network, 2019-2032 (USD Million)
• Table 67 Indonesia: AI in Pathology Market, by Component, 2019-2032 (USD Million)
• Table 68 Indonesia: AI in Pathology Market, by Application, 2019-2032 (USD Million)
• Table 69 Indonesia: AI in Pathology Market, by End Use, 2019-2032 (USD Million)
• Table 70 Malaysia: AI in Pathology Market, by Neural Network, 2019-2032 (USD Million)
• Table 71 Malaysia: AI in Pathology Market, by Component, 2019-2032 (USD Million)
• Table 72 Malaysia: AI in Pathology Market, by Application, 2019-2032 (USD Million)
• Table 73 Malaysia: AI in Pathology Market, by End Use, 2019-2032 (USD Million)
• Table 74 South Korea: AI in Pathology Market, by Neural Network, 2019-2032 (USD Million)
• Table 75 South Korea: AI in Pathology Market, by Component, 2019-2032 (USD Million)
• Table 76 South Korea: AI in Pathology Market, by Application, 2019-2032 (USD Million)
• Table 77 South Korea: AI in Pathology Market, by End Use, 2019-2032 (USD Million)
• Table 78 Latin America: AI in Pathology Market, by Neural Network, 2019-2032 (USD Million)
• Table 79 Latin America: AI in Pathology Market, by Component, 2019-2032 (USD Million)
• Table 80 Latin America: AI in Pathology Market, by Application, 2019-2032 (USD Million)
• Table 81 Latin America: AI in Pathology Market, by End Use, 2019-2032 (USD Million)
• Table 82 Brazil: AI in Pathology Market, by Neural Network, 2019-2032 (USD Million)
• Table 83 Brazil: AI in Pathology Market, by Component, 2019-2032 (USD Million)
• Table 84 Brazil: AI in Pathology Market, by Application, 2019-2032 (USD Million)
• Table 85 Brazil: AI in Pathology Market, by End Use, 2019-2032 (USD Million)
• Table 86 Mexico: AI in Pathology Market, by Neural Network, 2019-2032 (USD Million)
• Table 87 Mexico: AI in Pathology Market, by Component, 2019-2032 (USD Million)
• Table 88 Mexico: AI in Pathology Market, by Application, 2019-2032 (USD Million)
• Table 89 Mexico: AI in Pathology Market, by End Use, 2019-2032 (USD Million)
• Table 90 Argentina: AI in Pathology Market, by Neural Network, 2019-2032 (USD Million)
• Table 91 Argentina: AI in Pathology Market, by Component, 2019-2032 (USD Million)
• Table 92 Argentina: AI in Pathology Market, by Application, 2019-2032 (USD Million)
• Table 93 Argentina: AI in Pathology Market, by End Use, 2019-2032 (USD Million)
• Table 94 Middle East & Africa: AI in Pathology Market, by Neural Network, 2019-2032 (USD Million)
• Table 95 Middle East & Africa: AI in Pathology Market, by Component, 2019-2032 (USD Million)
• Table 96 Middle East & Africa: AI in Pathology Market, by Application, 2019-2032 (USD Million)
• Table 97 Middle East & Africa: AI in Pathology Market, by End Use, 2019-2032 (USD Million)
• Table 98 UAE: AI in Pathology Market, by Neural Network, 2019-2032 (USD Million)
• Table 99 UAE: AI in Pathology Market, by Component, 2019-2032 (USD Million)
• Table 100 UAE: AI in Pathology Market, by Application, 2019-2032 (USD Million)
• Table 101 UAE: AI in Pathology Market, by End Use, 2019-2032 (USD Million)
• Table 102 Saudi Arabia: AI in Pathology Market, by Neural Network, 2019-2032 (USD Million)
• Table 103 Saudi Arabia: AI in Pathology Market, by Component, 2019-2032 (USD Million)
• Table 104 Saudi Arabia: AI in Pathology Market, by Application, 2019-2032 (USD Million)
• Table 105 Saudi Arabia: AI in Pathology Market, by End Use, 2019-2032 (USD Million)
• Table 106 South Africa: AI in Pathology Market, by Neural Network, 2019-2032 (USD Million)
• Table 107 South Africa: AI in Pathology Market, by Component, 2019-2032 (USD Million)
• Table 108 South Africa: AI in Pathology Market, by Application, 2019-2032 (USD Million)
• Table 109 South Africa: AI in Pathology Market, by End Use, 2019-2032 (USD Million)
• Table 110 Israel: AI in Pathology Market, by Neural Network, 2019-2032 (USD Million)
• Table 111 Israel: AI in Pathology Market, by Component, 2019-2032 (USD Million)
• Table 112 Israel: AI in Pathology Market, by Application, 2019-2032 (USD Million)
• Table 113 Israel: AI in Pathology Market, by End Use, 2019-2032 (USD Million)

List of Figures

• Figure 1. Global AI in Pathology Market, 2019-2032 (USD Million)
• Figure 2. Integrated Ecosystem
• Figure 3. Research Methodology: Top-Down & Bottom-Up End Use
• Figure 4. Market by Geography
• Figure 5. Porter's Five Forces
• Figure 6. Market by Neural Network
• Figure 7. Global AI in Pathology Market, by Neural Network, 2021 & 2030 (USD Million)
• Figure 8. Market by End Use
• Figure 9. Global AI in Pathology Market, by End Use, 2021 & 2030 (USD Million)
• Figure 10. Market by Component
• Figure 11. Global AI in Pathology Market, by Component, 2021 & 2030 (USD Million)
• Figure 12. Market by Application
• Figure 13. Global AI in Pathology Market, by Application, 2021 & 2030 (USD Million)

The global AI in pathology market size is expected to reach USD 89.71 million by 2032, according to a new study by Polaris Market Research. The report "AI in pathology Market Share, Size, Trends, Industry Analysis Report, By Component (Software, Scanners); By Neural Network; By Application; By End User; By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Initially, pathologists are used to examine pathology slides using microscopes. Visual observation and subjective interpretation have become ineffective in preventing intra- and interobserver disagreement. This facilitated the use of artificial intelligence in pathology, as automated approaches will improve the speed and accuracy of results, primarily through digital imaging. A recent study published in PubMed Central in 2022 evaluated the application of AI in pathology, along with trends and challenges.

The rising use of AI in computer applications is gaining traction among pathologists. The evolution of artificial intelligence, along with deep learning, is enabling image-based diagnosis with a background in digital pathology. Furthermore, the use of artificial intelligence by pathologists will save time and reduce errors, driving its use primarily in laboratories with more cases in the coming years.

The growing adoption of digital pathology laboratories at the global level is driving the use of artificial intelligence in the various tasks in pathology. A study published in 2023 focused on reviewing the digitalization of pathology labs. It revealed the benefits of digitalization, including lower reading time for cases and the need for second opinions. Digital pathology makes the diagnosis process faster and more efficient as it uses machine learning and artificial intelligence for the identification of diseases, symptoms, and ailments. This will enable scientists and doctors to choose the best treatment options, resulting in better patient outcomes.

As researchers come forward to check the reliability of artificial intelligence in pathology, there will be a rise in awareness about it among doctors, which may increase the adoption rate in the next few years.

AI in Pathology Market Report Highlights

The software segment is anticipated to witness the highest growth in the coming years due to advanced algorithms and improved diagnostics.

Conventional neural network segment accounted for the largest market share owing to the application of AI in image analysis.

The drug discovery segment is projected to experience a larger revenue share due to its ability to provide personalized medication.

Hospitals and reference laboratory segments are expected to witness significant growth owing to the prevalence of a higher caseload related to pathology.

Asia Pacific is projected to register the largest growth rate in the study period owing to the growing healthcare AI market.

The global players include: 4D Path, Aiforia Technologies, Aiosyn, Akoya Biosciences, deepPath, Deep Bio, Hologic, Ibex Medical Analytics & Indica Labs.

Polaris Market Research has segmented the AI in pathology market report based on component, neural network, application, end user and region:

AI in Pathology, Component Outlook (Revenue - USD Million, 2019 - 2032)

• Software
• Scanners

AI in Pathology, Neural Network Outlook (Revenue - USD Million, 2019 - 2032)

• Generative adversarial networks (GANS)
• Convolutional neural networks (CNNs)
• Recurrent neural networks (RNNs)
• Others

AI in Pathology, Application Outlook (Revenue - USD Million, 2019 - 2032)

• Drug Discovery
• Disease Diagnosis & Prognosis
• Clinical Workflow
• Training & Education

AI in Pathology, End User Outlook (Revenue - USD Million, 2019 - 2032)

• Pharmaceutical & Biotechnology Companies
• Hospitals & Reference Laboratories
• Academic & Research Institutes

AI in Pathology, Regional Outlook (Revenue - USD Million, 2019 - 2032)

• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• France
• Italy
• Spain
• Russia
• Netherlands
• Asia Pacific
• China
• India
• Japan
• South Korea
• Indonesia
• Malaysia
• Latin America
• Argentina
• Brazil
• Mexico
• Middle East & Africa
• UAE
• Saudi Arabia
• Israel
• South Africa

Table of Contents

1. Introduction

• 1.1. Report Description
  • 1.1.1. Objectives of the Study
  • 1.1.2. Market Scope
  • 1.1.3. Assumptions
• 1.2. Stakeholders

2. Executive Summary

• 2.1. Market Highlights

3. Research Methodology

• 3.1. Overview
  • 3.1.1. Data Mining
• 3.2. Data Sources
  • 3.2.1. Primary Sources
  • 3.2.2. Secondary Sources

4. Global AI in Pathology Market Insights

• 4.1. AI in Pathology - Industry Snapshot
• 4.2. AI in Pathology Market Dynamics
  • 4.2.1. Drivers and Opportunities
    • 4.2.1.1. The global spread of diseases is driving the utilization of artificial intelligence
    • 4.2.1.2. Precision medicine advancements through ai integration
  • 4.2.2. Restraints and Challenges
    • 4.2.2.1. Integration challenges and workflow disruptions
• 4.3. Porter's Five Forces Analysis
  • 4.3.1. Bargaining Power of Suppliers (Moderate)
  • 4.3.2. Threats of New Entrants: (Low)
  • 4.3.3. Bargaining Power of Buyers (Moderate)
  • 4.3.4. Threat of Substitute (Moderate)
  • 4.3.5. Rivalry among existing firms (High)
• 4.4. PESTLE Analysis
• 4.5. AI in Pathology Industry Trends
• 4.6. Value Chain Analysis
• 4.7. COVID-19 Impact Analysis

5. Global AI in Pathology Market, by Neural Network

• 5.1. Key Findings
• 5.2. Introduction
  • 5.2.1. Global AI in Pathology Market, by Neural Network, 2019-2032 (USD Million)
• 5.3. Generative adversarial networks (GANS)
  • 5.3.1. Global AI in Pathology Market, by Generative adversarial networks (GANS), by Region, 2019-2032 (USD Million)
• 5.4. Convolutional neural networks (CNNs)
  • 5.4.1. Global AI in Pathology Market, by Convolutional neural networks (CNNs), by Region, 2019-2032 (USD Million)
• 5.5. Recurrent neural networks (RNNs)
  • 5.5.1. Global AI in Pathology Market, by Recurrent neural networks (RNNs), by Region, 2019-2032 (USD Million)
• 5.6. Others
  • 5.6.1. Global AI in Pathology Market, by Others, by Region, 2019-2032 (USD Million)

6. Global AI in Pathology Market, by Component

• 6.1. Key Findings
• 6.2. Introduction
  • 6.2.1. Global AI in Pathology Market, by Component, 2019-2032 (USD Million)
• 6.3. Software
  • 6.3.1. Global AI in Pathology Market, by Software, by Region, 2019-2032 (USD Million)
• 6.4. Scanners
  • 6.4.1. Global AI in Pathology Market, by Scanners, by Region, 2019-2032 (USD Million)

7. Global AI in Pathology Market, by Application

• 7.1. Key Findings
• 7.2. Introduction
  • 7.2.1. Global AI in Pathology Market, by Application, 2019-2032 (USD Million)
• 7.3. Drug Discovery
  • 7.3.1. Global AI in Pathology Market, by Drug Discovery, by Region, 2019-2032 (USD Million)
• 7.4. Diseax`se Diagnosis & Prognosis
  • 7.4.1. Global AI in Pathology Market, by Diseax`se Diagnosis & Prognosis, by Region, 2019-2032 (USD Million)
• 7.5. Clinical Workflow
  • 7.5.1. Global AI in Pathology Market, by Clinical Workflow, by Region, 2019-2032 (USD Million)
• 7.6. Training & Education
  • 7.6.1. Global AI in Pathology Market, by Training & Education, by Region, 2019-2032 (USD Million)

8. Global AI in Pathology Market, by End Use

• 8.1. Key Findings
• 8.2. Introduction
  • 8.2.1. Global AI in Pathology Market, by End Use, 2019-2032 (USD Million)
• 8.3. Pharmaceutical & Biotechnology Companies
  • 8.3.1. Global AI in Pathology Market, by Pharmaceutical & Biotechnology Companies, by Region, 2019-2032 (USD Million)
• 8.4. Hospitals & Reference Laboratories
  • 8.4.1. Global AI in Pathology Market, by Hospitals & Reference Laboratories, by Region, 2019-2032 (USD Million)
• 8.5. Academic & Research Institutes
  • 8.5.1. Global AI in Pathology Market, by Academic & Research Institutes, by Region, 2019-2032 (USD Million)

9. Global AI in Pathology Market, by Geography

• 9.1. Key findings
• 9.2. Introduction
  • 9.2.1. AI in Pathology Market Assessment, By Geography, 2019-2032 (USD Million)
• 9.3. AI in Pathology Market - North America
  • 9.3.1. North America: AI in Pathology Market, by Neural Network, 2019-2032 (USD Million)
  • 9.3.2. North America: AI in Pathology Market, by End Use, 2019-2032 (USD Million)
  • 9.3.3. North America: AI in Pathology Market, by Component, 2019-2032 (USD Million)
  • 9.3.4. North America: AI in Pathology Market, by Application, 2019-2032 (USD Million)
  • 9.3.5. AI in Pathology Market - U.S.
    • 9.3.5.1. U.S.: AI in Pathology Market, by Neural Network, 2019-2032 (USD Million)
    • 9.3.5.2. U.S.: AI in Pathology Market, by End Use, 2019-2032 (USD Million)
    • 9.3.5.3. U.S.: AI in Pathology Market, by Component, 2019-2032 (USD Million)
    • 9.3.5.4. U.S.: AI in Pathology Market, by Application, 2019-2032 (USD Million)
  • 9.3.6. AI in Pathology Market - Canada
    • 9.3.6.1. Canada: AI in Pathology Market, by Neural Network, 2019-2032 (USD Million)
    • 9.3.6.2. Canada: AI in Pathology Market, by End Use, 2019-2032 (USD Million)
    • 9.3.6.3. Canada: AI in Pathology Market, by Component, 2019-2032 (USD Million)
    • 9.3.6.4. Canada: AI in Pathology Market, by Application, 2019-2032 (USD Million)
• 9.4. AI in Pathology Market - Europe
  • 9.4.1. Europe: AI in Pathology Market, by Neural Network, 2019-2032 (USD Million)
  • 9.4.2. Europe: AI in Pathology Market, by End Use, 2019-2032 (USD Million)
  • 9.4.3. Europe: AI in Pathology Market, by Component, 2019-2032 (USD Million)
  • 9.4.4. Europe: AI in Pathology Market, by Application, 2019-2032 (USD Million)
  • 9.4.5. AI in Pathology Market - UK
    • 9.4.5.1. UK: AI in Pathology Market, by Neural Network, 2019-2032 (USD Million)
    • 9.4.5.2. UK: AI in Pathology Market, by End Use, 2019-2032 (USD Million)
    • 9.4.5.3. UK: AI in Pathology Market, by Component, 2019-2032 (USD Million)
    • 9.4.5.4. UK: AI in Pathology Market, by Application, 2019-2032 (USD Million)
  • 9.4.6. AI in Pathology Market - France
    • 9.4.6.1. France: AI in Pathology Market, by Neural Network, 2019-2032 (USD Million)
    • 9.4.6.2. France: AI in Pathology Market, by End Use, 2019-2032 (USD Million)
    • 9.4.6.3. France: AI in Pathology Market, by Component, 2019-2032 (USD Million)
    • 9.4.6.4. France: AI in Pathology Market, by Application, 2019-2032 (USD Million)
  • 9.4.7. AI in Pathology Market - Germany
    • 9.4.7.1. Germany: AI in Pathology Market, by Neural Network, 2019-2032 (USD Million)
    • 9.4.7.2. Germany: AI in Pathology Market, by End Use, 2019-2032 (USD Million)
    • 9.4.7.3. Germany: AI in Pathology Market, by Component, 2019-2032 (USD Million)
    • 9.4.7.4. Germany: AI in Pathology Market, by Application, 2019-2032 (USD Million)
  • 9.4.8. AI in Pathology Market - Italy
    • 9.4.8.1. Italy: AI in Pathology Market, by Neural Network, 2019-2032 (USD Million)
    • 9.4.8.2. Italy: AI in Pathology Market, by End Use, 2019-2032 (USD Million)
    • 9.4.8.3. Italy: AI in Pathology Market, by Component, 2019-2032 (USD Million)
    • 9.4.8.4. Italy: AI in Pathology Market, by Application, 2019-2032 (USD Million)
  • 9.4.9. AI in Pathology Market - Spain
    • 9.4.9.1. Spain: AI in Pathology Market, by Neural Network, 2019-2032 (USD Million)
    • 9.4.9.2. Spain: AI in Pathology Market, by End Use, 2019-2032 (USD Million)
    • 9.4.9.3. Spain: AI in Pathology Market, by Component, 2019-2032 (USD Million)
    • 9.4.9.4. Spain: AI in Pathology Market, by Application, 2019-2032 (USD Million)
  • 9.4.10. AI in Pathology Market - Netherlands
    • 9.4.10.1. Netherlands: AI in Pathology Market, by Neural Network, 2019-2032 (USD Million)
    • 9.4.10.2. Netherlands: AI in Pathology Market, by End Use, 2019-2032 (USD Million)
    • 9.4.10.3. Netherlands: AI in Pathology Market, by Component, 2019-2032 (USD Million)
    • 9.4.10.4. Netherlands: AI in Pathology Market, by Application, 2019-2032 (USD Million)
  • 9.4.11. AI in Pathology Market - Russia
    • 9.4.11.1. Russia: AI in Pathology Market, by Neural Network, 2019-2032 (USD Million)
    • 9.4.11.2. Russia.: AI in Pathology Market, by End Use, 2019-2032 (USD Million)
    • 9.4.11.3. Russia: AI in Pathology Market, by Component, 2019-2032 (USD Million)
    • 9.4.11.4. Russia: AI in Pathology Market, by Application, 2019-2032 (USD Million)
• 9.5. AI in Pathology Market - Asia Pacific
  • 9.5.1. Asia Pacific: AI in Pathology Market, by Neural Network, 2019-2032 (USD Million)
  • 9.5.2. Asia Pacific: AI in Pathology Market, by End Use, 2019-2032 (USD Million)
  • 9.5.3. Asia Pacific: AI in Pathology Market, by Component, 2019-2032 (USD Million)
  • 9.5.4. Asia Pacific: AI in Pathology Market, by Application, 2019-2032 (USD Million)
  • 9.5.5. AI in Pathology Market - China
    • 9.5.5.1. China: AI in Pathology Market, by Neural Network, 2019-2032 (USD Million)
    • 9.5.5.2. China.: AI in Pathology Market, by End Use, 2019-2032 (USD Million)
    • 9.5.5.3. China: AI in Pathology Market, by Component, 2019-2032 (USD Million)
    • 9.5.5.4. China: AI in Pathology Market, by Application, 2019-2032 (USD Million)
  • 9.5.6. AI in Pathology Market - India
    • 9.5.6.1. India: AI in Pathology Market, by Neural Network, 2019-2032 (USD Million)
    • 9.5.6.2. India.: AI in Pathology Market, by End Use, 2019-2032 (USD Million)
    • 9.5.6.3. India: AI in Pathology Market, by Component, 2019-2032 (USD Million)
    • 9.5.6.4. India: AI in Pathology Market, by Application, 2019-2032 (USD Million)
  • 9.5.7. AI in Pathology Market - Japan
    • 9.5.7.1. Japan: AI in Pathology Market, by Neural Network, 2019-2032 (USD Million)
    • 9.5.7.2. Japan.: AI in Pathology Market, by End Use, 2019-2032 (USD Million)
    • 9.5.7.3. Japan: AI in Pathology Market, by Component, 2019-2032 (USD Million)
    • 9.5.7.4. Japan: AI in Pathology Market, by Application, 2019-2032 (USD Million)
  • 9.5.8. AI in Pathology Market - Malaysia
    • 9.5.8.1. Malaysia: AI in Pathology Market, by Neural Network, 2019-2032 (USD Million)
    • 9.5.8.2. Malaysia.: AI in Pathology Market, by End Use, 2019-2032 (USD Million)
    • 9.5.8.3. Malaysia: AI in Pathology Market, by Component, 2019-2032 (USD Million)
    • 9.5.8.4. Malaysia: AI in Pathology Market, by Application, 2019-2032 (USD Million)
  • 9.5.9. AI in Pathology Market - Indonesia
    • 9.5.9.1. Indonesia: AI in Pathology Market, by Neural Network, 2019-2032 (USD Million)
    • 9.5.9.2. Indonesia.: AI in Pathology Market, by End Use, 2019-2032 (USD Million)
    • 9.5.9.3. Indonesia: AI in Pathology Market, by Component, 2019-2032 (USD Million)
    • 9.5.9.4. Indonesia: AI in Pathology Market, by Application, 2019-2032 (USD Million)
  • 9.5.10. AI in Pathology Market - South Korea
    • 9.5.10.1. South Korea: AI in Pathology Market, by Neural Network, 2019-2032 (USD Million)
    • 9.5.10.2. South Korea.: AI in Pathology Market, by End Use, 2019-2032 (USD Million)
    • 9.5.10.3. South Korea: AI in Pathology Market, by Component, 2019-2032 (USD Million)
    • 9.5.10.4. South Korea: AI in Pathology Market, by Application, 2019-2032 (USD Million)
• 9.6. AI in Pathology Market - Middle East & Africa
  • 9.6.1. Middle East & Africa: AI in Pathology Market, by Neural Network, 2019-2032 (USD Million)
  • 9.6.2. Middle East & Africa: AI in Pathology Market, by End Use, 2019-2032 (USD Million)
  • 9.6.3. Middle East & Africa: AI in Pathology Market, by Component, 2019-2032 (USD Million)
  • 9.6.4. Middle East & Africa: AI in Pathology Market, by Application, 2019-2032 (USD Million)
  • 9.6.5. AI in Pathology Market - Saudi Arabia
    • 9.6.5.1. Saudi Arabia: AI in Pathology Market, by Neural Network, 2019-2032 (USD Million)
    • 9.6.5.2. Saudi Arabia: AI in Pathology Market, by End Use, 2019-2032 (USD Million)
    • 9.6.5.3. Saudi Arabia: AI in Pathology Market, by Component, 2019-2032 (USD Million)
    • 9.6.5.4. Saudi Arabia: AI in Pathology Market, by Application, 2019-2032 (USD Million)
  • 9.6.6. AI in Pathology Market - South Africa
    • 9.6.6.1. South Africa: AI in Pathology Market, by Neural Network, 2019-2032 (USD Million)
    • 9.6.6.2. South Africa: AI in Pathology Market, by End Use, 2019-2032 (USD Million)
    • 9.6.6.3. South Africa: AI in Pathology Market, by Component, 2019-2032 (USD Million)
    • 9.6.6.4. South Africa: AI in Pathology Market, by Application, 2019-2032 (USD Million)
  • 9.6.7. AI in Pathology Market - Israel
    • 9.6.7.1. Israel: AI in Pathology Market, by Neural Network, 2019-2032 (USD Million)
    • 9.6.7.2. Israel: AI in Pathology Market, by End Use, 2019-2032 (USD Million)
    • 9.6.7.3. Israel: AI in Pathology Market, by Component, 2019-2032 (USD Million)
    • 9.6.7.4. Israel: AI in Pathology Market, by Application, 2019-2032 (USD Million)
  • 9.6.8. AI in Pathology Market - UAE
    • 9.6.8.1. UAE: AI in Pathology Market, by Neural Network, 2019-2032 (USD Million)
    • 9.6.8.2. UAE: AI in Pathology Market, by End Use, 2019-2032 (USD Million)
    • 9.6.8.3. UAE: AI in Pathology Market, by Component, 2019-2032 (USD Million)
    • 9.6.8.4. UAE: AI in Pathology Market, by Application, 2019-2032 (USD Million)
• 9.7. AI in Pathology Market - Latin America
  • 9.7.1. Latin America: AI in Pathology Market, by Neural Network, 2019-2032 (USD Million)
  • 9.7.2. Latin America: AI in Pathology Market, by End Use, 2019-2032 (USD Million)
  • 9.7.3. Latin America: AI in Pathology Market, by Component, 2019-2032 (USD Million)
  • 9.7.4. Latin America: AI in Pathology Market, by Application, 2019-2032 (USD Million)
  • 9.7.5. AI in Pathology Market - Mexico
    • 9.7.5.1. Mexico: AI in Pathology Market, by Neural Network, 2019-2032 (USD Million)
    • 9.7.5.2. Mexico: AI in Pathology Market, by End Use, 2019-2032 (USD Million)
    • 9.7.5.3. Mexico: AI in Pathology Market, by Component, 2019-2032 (USD Million)
    • 9.7.5.4. Mexico: AI in Pathology Market, by Application, 2019-2032 (USD Million)
  • 9.7.6. AI in Pathology Market - Brazil
    • 9.7.6.1. Brazil: AI in Pathology Market, by Neural Network, 2019-2032 (USD Million)
    • 9.7.6.2. Brazil: AI in Pathology Market, by End Use, 2019-2032 (USD Million)
    • 9.7.6.3. Brazil: AI in Pathology Market, by Component, 2019-2032 (USD Million)
    • 9.7.6.4. Brazil: AI in Pathology Market, by Application, 2019-2032 (USD Million)
  • 9.7.7. AI in Pathology Market - Argentina
    • 9.7.7.1. Argentina: AI in Pathology Market, by Neural Network, 2019-2032 (USD Million)
    • 9.7.7.2. Argentina: AI in Pathology Market, by End Use, 2019-2032 (USD Million)
    • 9.7.7.3. Argentina: AI in Pathology Market, by Component, 2019-2032 (USD Million)
    • 9.7.7.4. Argentina: AI in Pathology Market, by Application, 2019-2032 (USD Million)

10. Competitive Landscape

• 10.1. Expansion and Acquisition Analysis
  • 10.1.1. Expansion
  • 10.1.2. Acquisitions
• 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

• 11.1. 4D Path
  • 11.1.1. Company Overview
  • 11.1.2. Financial Performance
  • 11.1.3. Product Benchmarking
  • 11.1.4. Recent Development
• 11.2. Aiforia Technologies
  • 11.2.1. Company Overview
  • 11.2.2. Financial Performance
  • 11.2.3. Product Benchmarking
  • 11.2.4. Recent Development
• 11.3. Aiosyn
  • 11.3.1. Company Overview
  • 11.3.2. Financial Performance
  • 11.3.3. Product Benchmarking
  • 11.3.4. Recent Development
• 11.4. Akoya Biosciences
  • 11.4.1. Company Overview
  • 11.4.2. Financial Performance
  • 11.4.3. Product Benchmarking
  • 11.4.4. Recent Development
• 11.5. deepPath
  • 11.5.1. Company Overview
  • 11.5.2. Financial Performance
  • 11.5.3. Product Benchmarking
  • 11.5.4. Recent Development
• 11.6. Deep Bio
  • 11.6.1. Company Overview
  • 11.6.2. Financial Performance
  • 11.6.3. Product Benchmarking
  • 11.6.4. Recent Development
• 11.7. DoMore Diagnostics AS
  • 11.7.1. Company Overview
  • 11.7.2. Financial Performance
  • 11.7.3. Product Benchmarking
  • 11.7.4. Recent Development
• 11.8. F. Hoffmann-La Roche
  • 11.8.1. Company Overview
  • 11.8.2. Financial Performance
  • 11.8.3. Product Benchmarking
  • 11.8.4. Recent Development
• 11.9. Hologic
  • 11.9.1. Company Overview
  • 11.9.2. Financial Performance
  • 11.9.3. Product Benchmarking
  • 11.9.4. Recent Development
• 11.10. Ibex Medical Analytics
  • 11.10.1. Company Overview
  • 11.10.2. Financial Performance
  • 11.10.3. Product Benchmarking
  • 11.10.4. Recent Development
• 11.11. Indica Labs
  • 11.11.1. Company Overview
  • 11.11.2. Financial Performance
  • 11.11.3. Product Benchmarking
  • 11.11.4. Recent Development
• 11.12. Konfoong Biotech International
  • 11.12.1. Company Overview
  • 11.12.2. Financial Performance
  • 11.12.3. Product Benchmarking
  • 11.12.4. Recent Development
• 11.13. Koninklijke Philips N.V.
  • 11.13.1. Company Overview
  • 11.13.2. Financial Performance
  • 11.13.3. Product Benchmarking
  • 11.13.4. Recent Development
• 11.14. Lumea
  • 11.14.1. Company Overview
  • 11.14.2. Financial Performance
  • 11.14.3. Product Benchmarking
  • 11.14.4. Recent Development
• 11.15. Mindpeak
  • 11.15.1. Company Overview
  • 11.15.2. Financial Performance
  • 11.15.3. Product Benchmarking
  • 11.15.4. Recent Development